Peptides in the regulation of glucagon secretion

The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

(2021) Anna Thorsø Larsen et al.   BMC Endocrine Disorders

Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

(2021) David S. Mathiesen et al.   Frontiers in Endocrinology

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide

(2021) Michele Schiavon et al.   DIABETES OBESITY & METABOLISM

Regulation of Pancreatic β-cell Function by the NPY System

(2021) Chieh-Hsin Yang et al.   ENDOCRINOLOGY

β Cell GHS-R Regulates Insulin Secretion and Sensitivity

(2021) Geetali Pradhan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

(2021) Lone B Enebo et al.   LANCET

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

(2021) Rajaa Nahra et al.   DIABETES CARE

Weight‐reducing, lipid‐lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high‐fat‐fed mice

(2021) Shruti Mohan et al.   DIABETES OBESITY & METABOLISM

Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity

(2021) Mathies M. Jepsen et al.   EXPERT OPINION ON EMERGING DRUGS

The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans

(2021) Liya Kerem et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk

(2021) Wei He et al.   Frontiers in Endocrinology

KATP channel blockers control glucagon secretion by distinct mechanisms: A direct stimulation of α-cells involving a [Ca2+]c rise and an indirect inhibition mediated by somatostatin

(2021) Bilal Singh et al.   Molecular Metabolism

In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose‐induced inhibition of glucagon secretion

(2020) Stella F.S. Xu et al.   Acta Physiologica

Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high fat diet

(2020) Joely A. Kellard et al.   Molecular Metabolism

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs

(2020) Caitlin L. Maikawa et al.   Nature Biomedical Engineering

The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition

(2020) Sofie Hædersdal et al.   DIABETES

Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets

(2020) Berit Svendsen et al.   DIABETOLOGIA

Experience with Teduglutide in Pediatric Short Bowel Syndrome

(2020) Esther Ramos Boluda et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes

(2020) Olof Eriksson et al.   Scientific Reports

Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study

(2020) Nina L. Hansen et al.   Clinical and Translational Gastroenterology

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

(2020) Marie Winther-Sørensen et al.   Molecular Metabolism

The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease

(2020) Katrine D. Galsgaard   Journal of Clinical Medicine

Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice

(2020) Shruti Mohan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival

(2019) Shruti Mohan et al.   BIOCHIMIE

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion

(2019) Elisa Vergari et al.   Nature Communications

The liver-alpha cell axis and type 2 diabetes

(2019) Nicolai J Wewer Albrechtsen et al.   ENDOCRINE REVIEWS

No direct effect of SGLT2 activity on glucagon secretion

(2019) Rune E. Kuhre et al.   DIABETOLOGIA

A Long-Acting PYY3–36 Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates

(2019) Shamina M. Rangwala et al.   Cell Metabolism

Glucose and Amino Acid Metabolism in Mice Depend Mutually on Glucagon and Insulin Receptor Signaling

(2019) Katrine D. Galsgaard et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway

(2019) Cecilia Ratner et al.   DIABETES

Glucose controls glucagon secretion by directly modulating cAMP in alpha cells

(2019) Qian Yu et al.   DIABETOLOGIA

Intra-Islet Ghrelin Signaling does not Regulate Insulin Secretion from Adult Mice

(2019) Sarah. M. Gray et al.   DIABETES

A Primary Role for Alpha Cells as Amino Acid Sensors

(2019) E. Danielle Dean   DIABETES

The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis

(2019) Elizabeth A. Lawson et al.   JOURNAL OF NEUROENDOCRINOLOGY

The role of GIP in α-cells and glucagon secretion

(2019) Kimberley El et al.   PEPTIDES

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy

(2018) Robert Martinez et al.   DIABETES

Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

(2018) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

(2018) Sofie Hædersdal et al.   MAYO CLINIC PROCEEDINGS

Problem or solution: The strange story of glucagon

(2018) R.V. Scott et al.   PEPTIDES

Oxyntomodulin: Actions and role in diabetes

(2018) Jens J. Holst et al.   PEPTIDES

Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice

(2018) Rasmus Hytting-Andreasen et al.   PLoS One

Somatostatin is Only Partly Required for the Glucagonostatic Effect of Glucose but is Necessary for the Glucagonostatic Effect of KATPChannel Blockers

(2018) Bao-Khanh Lai et al.   DIABETES

GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner

(2018) Yanqing Zhang et al.   DIABETES

Design of Y2 Receptor Selective and Proteolytically Stable PYY3–36 Analogues

(2018) Søren Østergaard et al.   JOURNAL OF MEDICINAL CHEMISTRY

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

(2018) Juan Pablo Frias et al.   LANCET

The Difference δ-Cells Make in Glucose Control

(2018) Mark O. Huising et al.   PHYSIOLOGY

Insulin Secretion Depends on Intra-islet Glucagon Signaling

(2018) Berit Svendsen et al.   Cell Reports

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

(2018) Takayoshi Suga et al.   Molecular Metabolism

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

(2017) M. Pilar Valdecantos et al.   HEPATOLOGY

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

(2017) Tricia Tan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin

(2017) L. J. B. Briant et al.   JOURNAL OF PHYSIOLOGY-LONDON

Biochemical and cellular properties of insulin receptor signalling

(2017) Rebecca A. Haeusler et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes

(2017) Claudia Guida et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Inhibition of Y1 receptor signaling improves islet transplant outcome

(2017) Kim Loh et al.   Nature Communications

Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects

(2016) William S. Denney et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes

(2016) Åsa Segerstolpe et al.   Cell Metabolism

Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets

(2016) Alice E. Adriaenssens et al.   DIABETOLOGIA

Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery

(2016) Cecilia Ratner et al.   ENDOCRINOLOGY

Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1

(2016) Jenny Tong et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

An obligatory role for neurotensin in high-fat-diet-induced obesity

(2016) Jing Li et al.   NATURE

Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells

(2016) Yurong Xin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pancreatic islet blood flow and its measurement

(2016) Leif Jansson et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion

(2016) Frank Reimann et al.   Journal of Diabetes Investigation

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

(2016) Nicolai J. Wewer Albrechtsen et al.   EBioMedicine

Oxytocin Protects against Stress-Induced Cell Death in Murine Pancreatic β-Cells

(2016) Sayaka Watanabe et al.   Scientific Reports

Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP

(2015) Amicia D. Elliott et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Pancreatic polypeptide regulates glucagon release through PPYR1 receptors expressed in mouse and human alpha-cells

(2015) F. Aragón et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Pancreatic PYY Is Critical in the Control of Insulin Secretion and Glucose Homeostasis in Female Mice

(2015) Yan-Chuan Shi et al.   ENDOCRINOLOGY

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

(2015) Jonatan Ising Bagger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men

(2015) S. Goya Wannamethee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion

(2015) Talitha van der Meulen et al.   NATURE MEDICINE

Ghrelin

(2015) T.D. Müller et al.   Molecular Metabolism

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes

(2014) Siri Fredheim et al.   DIABETOLOGIA

ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion

(2014) Patrik Rorsman et al.   DIABETOLOGIA

Peptide YY: more than just an appetite regulator

(2014) Shanta J. Persaud et al.   DIABETOLOGIA

Divergent Effects of Oxytocin Treatment of Obese Diabetic Mice on Adiposity and Diabetes

(2014) Jordi Altirriba et al.   ENDOCRINOLOGY

Pancreatic polypeptide inhibits somatostatin secretion

(2014) Wook Kim et al.   FEBS LETTERS

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

(2014) Aurora Merovci et al.   JOURNAL OF CLINICAL INVESTIGATION

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

(2014) Ele Ferrannini et al.   JOURNAL OF CLINICAL INVESTIGATION

Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas

(2014) Beatrice Waser et al.   MODERN PATHOLOGY

Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias

(2014) Kim Vietz Andreassen et al.   PLoS One

A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity

(2013) Elisabetta Bianchi et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes

(2013) Quan Zhang et al.   Cell Metabolism

Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

(2013) Sreeneeranj Kasichayanula et al.   CLINICAL PHARMACOKINETICS

Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

(2013) Jens Juul Holst   CURRENT OPINION IN PHARMACOLOGY

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats

(2013) Negar Karimian et al.   DIABETES

Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose: Involvement of KATP Channels From Both  -Cells and  -Cells

(2013) R. Cheng-Xue et al.   DIABETES

Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency

(2013) H. E. Wilson-Perez et al.   DIABETES

Calcitonin: Physiology or fantasy?

(2013) Rachel A Davey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

(2013) Robert R. Henry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity

(2013) Eleanor Wheeler et al.   NATURE GENETICS

An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans

(2013) Stefan Amisten et al.   PHARMACOLOGY & THERAPEUTICS

The localization of oxytocin receptors in the islets of Langerhans in the rat pancreas

(2013) Motoaki Suzuki et al.   REGULATORY PEPTIDES

Role of oxytocin signaling in the regulation of body weight

(2013) James E. Blevins et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance

(2013) Keval Chandarana et al.   Molecular Metabolism

Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency

(2013) Mohamad Mokadem et al.   Molecular Metabolism

Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin

(2013) Qian Wang et al.   Molecular Metabolism

Regulation of the human Na+-dependent glucose cotransporter hSGLT2

(2012) Chiara Ghezzi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells

(2012) Balrik Kailey et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

(2012) M. Nauck et al.   DIABETES OBESITY & METABOLISM

Selective Ablation of Peptide YY Cells in Adult Mice Reveals Their Role in Beta Cell Survival

(2012) Amir H. Sam et al.   GASTROENTEROLOGY

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

(2012) S Enhörning et al.   INTERNATIONAL JOURNAL OF OBESITY

Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis

(2012) Charlotte X. Dong et al.   Nature Reviews Gastroenterology & Hepatology

Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axis

(2012) Peter Holzer et al.   NEUROPEPTIDES

Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems

(2012) Taka-aki Koshimizu et al.   PHYSIOLOGICAL REVIEWS

Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release

(2012) S. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neurotensin and its receptors in the control of glucose homeostasis

(2012) Jean Mazella et al.   Frontiers in Endocrinology

Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats

(2011) J. T. Y. Yue et al.   DIABETES

Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

(2011) M. Christensen et al.   DIABETES

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice

(2011) Y. Lee et al.   DIABETES

Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?

(2011) J. N. Walker et al.   DIABETES OBESITY & METABOLISM

Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs

(2011) K. R. Hjøllund et al.   DIABETOLOGIA

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy

(2011) Gherardo Mazziotti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes

(2011) Marta Busnelli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?

(2011) N M Whalley et al.   JOURNAL OF ENDOCRINOLOGY

Ghrelin Directly Stimulates Glucagon Secretion from Pancreatic α-Cells

(2011) Jen-Chieh Chuang et al.   MOLECULAR ENDOCRINOLOGY

Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats

(2011) Nicolas Deblon et al.   PLoS One

Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon

(2010) Antonella Amato et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

GLP-1 Inhibits and Adrenaline Stimulates Glucagon Release by Differential Modulation of N- and L-Type Ca2+ Channel-Dependent Exocytosis

(2010) Yang Z. De Marinis et al.   Cell Metabolism

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

(2010) K. J. Hare et al.   DIABETES

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans

(2010) J. Tong et al.   DIABETES

Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents

(2010) Y-L Liu et al.   INTERNATIONAL JOURNAL OF OBESITY

Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?

(2010) Meena Asmar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bowels control brain: gut hormones and obesity

(2010) Benjamin C. T. Field et al.   Nature Reviews Endocrinology

Somatostatin Receptor Subtypes in Human Type 2 Diabetic Islets

(2010) Guida M. Portela-Gomes et al.   PANCREAS

Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice

(2010) T.-J. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

(2010) Mikkel Christensen et al.   REGULATORY PEPTIDES

Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo

(2009) Dan Kawamori et al.   Cell Metabolism

Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes

(2009) C. W. Chia et al.   DIABETES

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight

(2009) C M Mack et al.   INTERNATIONAL JOURNAL OF OBESITY

Low Sympathetic Tone and Obese Phenotype in Oxytocin-deficient Mice

(2009) Claudia Camerino   Obesity

Amplification of pulsatile glucagon counterregulation by switch-off of α-cell-suppressing signals in streptozotocin-treated rats

(2008) Leon S. Farhy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study

(2008) Ralph A. DeFronzo et al.   CURRENT MEDICAL RESEARCH AND OPINION

Somatostatin Secreted by Islet  -Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function

(2008) A. C. Hauge-Evans et al.   DIABETES

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

(2008) J. de Heer et al.   DIABETOLOGIA

The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances β-Cell Function but Does Not Inhibit Gastric Emptying in Mice

(2008) Adriano Maida et al.   ENDOCRINOLOGY

Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes

(2008) A Viardot et al.   INTERNATIONAL JOURNAL OF OBESITY

Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium

(2008) Martha G. Welch et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Central mechanisms of osmosensation and systemic osmoregulation

(2008) Charles W. Bourque   NATURE REVIEWS NEUROSCIENCE

Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet

(2007) Edwin T. Parlevliet et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM